Merck's Keytruda helps lung cancer patients live longer in trial
Go back to Merck's Keytruda helps lung cancer patients live longer in trial| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 1,201,117 | |||||
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 61.97 +2.69 (4.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.28 | 52 Week High | $77.12 | |||
| Open | $60.67 | 52 Week Low | $49.03 | |||
| Day High | $62.25 | P/E | 40.24 | |||
| Day Low | $60.39 | EPS | $1.54 | |||
| Volume | 2,897,527 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 150.54 +3.17 (2.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.37 | 52 Week High | $65.46 | |||
| Open | $149.70 | 52 Week Low | $47.97 | |||
| Day High | $152.34 | P/E | 102.41 | |||
| Day Low | $149.37 | EPS | $1.47 | |||
| Volume | 1,832,684 | |||||



